De Jong A, Plat J, Bast A, Godschalk R W L, Basu S, Mensink R P
Department of Human Biology, Maastricht University, Maastricht, The Netherlands.
Eur J Clin Nutr. 2008 Feb;62(2):263-73. doi: 10.1038/sj.ejcn.1602733. Epub 2007 May 9.
The present study was designed to examine for the first time, side-by-side, the effects of plant sterol and stanol consumption on lipid metabolism and markers of antioxidant status, oxidative stress, endothelial dysfunction and low-grade inflammation in subjects on stable statin-treatment.
Double-blind, randomized, placebo-controlled, intervention trial.
University.
Forty-five patients on current statin treatment were recruited via newspaper advertisements. Data of 41 patients were used in statistical analysis.
Subjects consumed margarine with no added plant sterols or stanols for 4 weeks and were then divided into three groups of 15 subjects. For the next 16 weeks, one group continued with the control margarine and the other two groups with either a plant sterol- or stanol (2.5 g/day)-enriched margarine. Blood was sampled at the end of the run-in and intervention periods.
Plant sterol and stanol consumption significantly (P=0.026) reduced low-density lipoprotein (LDL) cholesterol by 0.34 mmol/l (95% confidence interval (CI), -0.67 to -0.04 mmol/l). No effects were shown on enzymatic and non-enzymatic antioxidants and markers of oxidative modification of lipids and DNA. In addition, no effect was found on soluble adhesion molecules, C-reactive protein and monocyte chemotactic protein-1 concentrations.
We conclude that 16 weeks of plant sterol or stanol consumption did not affect markers of antioxidant status, oxidative stress, endothelial dysfunction and low-grade inflammation in patients on stable statin treatment, despite a significant reduction of LDL cholesterol.
本研究首次旨在同时考察植物甾醇和甾烷醇的摄入对接受稳定他汀类药物治疗的受试者脂质代谢以及抗氧化状态、氧化应激、内皮功能障碍和低度炎症标志物的影响。
双盲、随机、安慰剂对照干预试验。
大学。
通过报纸广告招募了45名正在接受他汀类药物治疗的患者。41名患者的数据用于统计分析。
受试者食用不含添加植物甾醇或甾烷醇的人造黄油4周,然后分为三组,每组15名受试者。在接下来的16周里,一组继续食用对照人造黄油,另外两组分别食用富含植物甾醇(2.5克/天)或甾烷醇的人造黄油。在导入期和干预期结束时采集血样。
摄入植物甾醇和甾烷醇显著(P = 0.026)降低低密度脂蛋白(LDL)胆固醇0.34毫摩尔/升(95%置信区间(CI),-0.67至-0.04毫摩尔/升)。对酶促和非酶促抗氧化剂以及脂质和DNA氧化修饰标志物均无影响。此外,对可溶性黏附分子、C反应蛋白和单核细胞趋化蛋白-1浓度也无影响。
我们得出结论,尽管低密度脂蛋白胆固醇显著降低,但在接受稳定他汀类药物治疗的患者中,摄入16周的植物甾醇或甾烷醇对抗氧化状态、氧化应激、内皮功能障碍和低度炎症标志物没有影响。